You are here

Article info

Article menu

Download PDFPDF

Electronic pages
Correspondence response
Further thoughts about the ILLUMINATE studies of tabalumab in SLE
Free

Authors

  1. Correspondence to Professor David Isenberg, Division of Medicine, UCL, Centre for Rheumatology Research, London WC1E 6JF, UK; d.isenberg{at}ucl.ac.uk
View Full Text

Citation

Isenberg D
Further thoughts about the ILLUMINATE studies of tabalumab in SLE
Annals of the Rheumatic Diseases 2016;75:e11.

Publication history

  • Received October 5, 2015
  • Accepted October 10, 2015
  • First published November 3, 2015.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/